Genetic & virulence profiling of ESBL-positive E. coli from nosocomial & veterinary sources by Tyrrell, Jonathan M. et al.
Veterinary Microbiology 186 (2016) 37–43Genetic & virulence proﬁling of ESBL-positive E. coli from nosocomial &
veterinary sources
J.M. Tyrrella,*, M. Woottonb, M.A. Tolemana, R.A. Howea, M. Woodwardc, T.R. Walsha
aDepartment of Medical Microbiology & Infectious Disease, Heath Hospital, Cardiff CF14 4XW, UK
b Public Health Wales Microbiology Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK
cDepartment of Food & Nutritional Studies, University of Reading, RG6 6AP, UK
A R T I C L E I N F O
Article history:
Received 2 February 2015
Received in revised form 8 December 2015
Accepted 11 February 2016
Keywords:
E. coli
ESBL (Extended spectrum beta-lactamases)
CTX-M-14
Virulence
Pathogenicity
A B S T R A C T
CTX-M genes are the most prevalent ESBL globally, inﬁltrating nosocomial, community and
environmental settings. Wild and domesticated animals may act as effective vectors for the
dissemination of CTX-producing Enterobacteriaceae. This study aimed to contextualise blaCTX-M-14-
positive, cephalosporin-resistant Enterobacteriaceae human infections and compared resistance and
pathogenicity markers with veterinary isolates.
Epidemiologically related human (n = 18) and veterinary (n = 4) blaCTX-M-14-positive E. coli were fully
characterised. All were typed by XbaI pulsed ﬁeld gel electrophoresis and ST. Chromosomal/plasmidic
locations of blaCTX-M-14 were deduced by S1-nuclease digestion, and association with ISEcp1 was
investigated by sequencing. Conjugation experiments assessed transmissibility of plasmids carrying
blaCTX-M-14. Presence of virulence determinants was screened by PCR assay and pathogenicity potential
was determined by in vitro Galleria mellonella infection models.
84% of clinical E. coli originated from community patients. blaCTX-M-14 was found ubiquitously
downstream of ISEcp1 upon conjugative plasmids (25–150 kb). blaCTX-M-14 was also found upon the
chromosome of eight E. coli isolates. CTX-M-14-producing E. coli were found at multiple hospital sites.
Clonal commonality between patient, hospitals and livestock microbial populations was found. In vivo
model survival rates from clinical isolates (30%) and veterinary isolates (0%) were signiﬁcantly different
(p < 0.05). Co-transfer of blaCTX-M-14 and virulence determinants was demonstrated.
There is evidence of clonal spread of blaCTX-M-14-positive E. coli involving community patients and farm
livestock. blaCTX-M-14 positive human clinical isolates carry a lower intrinsic pathogenic potential than
veterinary E. coli highlighting the need for greater veterinary practices in preventing dissemination of
MDR E. coli among livestock.
ã 2016 Published by Elsevier B.V.
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The occurrence of ESBLs (Extended Spectrum b-lactamases)
carried by Enterobacteriaceae has increased signiﬁcantly in the last
decade. First identiﬁed in the 1980s (Matsumoto et al., 1988), CTX-
M-type ESBLs have now established a global presence and in most
countries are the most prevalent ESBL (Canton and Coque, 2006;
Bonnet, 2004). The CTX-M enzyme family is sub-categorised into
ﬁve major clusters, group 1, 2, 8, 9 and 25, and now includes
172 distinct gene sequences (at the time of writing) (http://lahey.
org/Studies/). blaCTX-M-14 is the precursor of the CTX-M Group
9 cluster, showing 100% homology to the chromosomal* Corresponding author.
E-mail address: tyrrelljm@cardiff.ac.uk (J.M. Tyrrell).
http://dx.doi.org/10.1016/j.vetmic.2016.02.007
0378-1135/ã 2016 Published by Elsevier B.V.b-lactamase, KLUY-1, from Kluyvera georgina (Olson et al.,
2005). CTX-M-14 is encoded by two distinct genetic sequences;
blaCTX-M-14a (GenBank Accession No. AF252622) and blaCTX-M-14b
(GenBank Accession No. D1359215) separated by 2 silent
mutations (Navarro et al., 2007). On a global persp
ective, blaCTX-M-14 is the second most commonly reported
CTX-M, after blaCTX-M-15 (Hawkey and Jones, 2009). There are
clinical reports worldwide, but in particular CTX-M-14 is the
dominant ESBL enzyme in both Asia and the Iberian regions of
Europe (Canton and Coque, 2006; Valverde et al., 2009; Hawkey,
2008).
Despite reports of clonal outbreaks (Pitout et al., 2005a), the
global foothold of blaCTX-M-14 can be most accurately attributed to
the mobility of its immediate genetic context, and its recruitment
onto conjugative plasmids. Although there are increasing reports
of blaCTX-M-14 linked with ISCR1 elements (Bae et al., 2007),
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ing genetic context. Additionally, blaCTX-M-14 is found upon a
diverse range of conjugative plasmid types, including IncA/C,
IncHI2, IncI, but favouring IncF and IncK in Asian and Iberian
regions, respectively (Wang et al., 2012; Ho et al., 2012; Valverde
et al., 2009).
CTX-M-positive infections are striking in their high rates of
community incidence when compared to that of nosocomial
settings (Pitout et al., 2005a,b). Outside of the clinical sector, blaCTX-
M-14 has been reported in bacterial specimens from a range of wild
and domesticated animals; birds of prey (Costa et al., 2008),
farmed ﬁsh (Jiang et al., 2012), gulls (Hernandez et al., 2010), pigs
(Brinas et al., 2003), poultry (Smet et al., 2008), rabbits (Blanc et al.,
2006) and wolves (Goncalves et al., 2011).
Work by Teale et al. (2005) and Liebana et al. (2006) reported
the ﬁrst incident of CTX-M-positive livestock infection in the UK
including a blaCTX-M-14-positive E. coli. It was unknown whether
these ﬁndings were isolated incidents, or signs of a new/emerging/
established antibiotic resistance reservoir. Assumptions on the
prevalence of antibiotic resistance gene carriage in livestock
specimens would be ill informed and unsubstantiated, and so
nationwide surveillance studies were initiated (Snow et al., 2011,
2012). Concurrently, the Specialist Antimicrobial Chemotherapy
Unit (SACU) conducted a Wales-wide targeted surveillance of 3rd
generation cephalosporin (3GC) resistant Enterobacterieaceae.
Our current work aims to contextualise the discoveries of Teale
et al. (2005) and Liebana et al. (2006) with regards to the blaCTX-M-
14 incidence in 3GC-resistant Enterobacteriaceae causing human
infection, and compare veterinary and human clinical isolates.ble 1
aracteristics relating to phenotype & epidemiology of antibiotic resistance of blaCTX-M-
XbaI Typee Isolate
#
Sourcea ST
Type
blaCTX-M-14
Variant
blaCTX-M14
Locationb
I #5714 Bangor (C) 538 a 75 kb, Ch 
#5722 Bangor (C) 538 a 75 kb 
II #5715 Bangor (C) 718 a 100 kb & Ch 
#5740 Bangor (C) 718 a 100 kb 
III #3336 Wrexham (C) 405 a 150 kb 
#3021 Newport (H) 405 a 75 kb 
#6478 (V) 10 a 75 kb & Ch 
#6479 (V) 10 a 25 kb & 75 kb 
IV #3081 Newport (C) 38 b Ch 
#3202 Cardiff (C) 38 a Ch 
– #6480 (V) 10 a 75 kb 
– #3018 Newport (H) 38 a 75 kb 
– #5729 Bangor (C) 410 a 75 kb 
– #2813 Aberystwyth
(C)
1193 a 100 kb 
– #2864 Carmarthen (C) 73 a 100 kb 
– #3221 Cardiff (C) 641 a 100 kb 
– #3253 Cardiff (C) 648 a 100 kb 
– #5682 Bangor (H) 131 a 100 kb 
– #6477 (V) 226 a 100 kb & Ch 
– #5737 Bangor (C) 131 a 150 kb 
– #3341 Wrexham (C) 38 a Ch 
– #5720 Bangor (C) 38 b Ch 
ICs of ciproﬂoxacin (CIPRO), cefotaxime (CTX) and ceftazidime (CAZ) with/without cla
a Indicates collection site and origin of specimen (C-community, H-hospital, V-veterina
b Plasmidic (kb) or chromosomal (Ch) location of blaCTX-M-14.
c Presence of full (U2) or truncated (U1) copy of the ISEcp1 insertion element upstream
e XbaI/PFGE types. E. coli shown to be clonal were grouped I,II, III and IV.2. Methods
2.1. Bacterial isolates
Cefpodoxime-resistant Enterobacteriaceae (n = 580) were col-
lected and characterised as part of a nation-wide 3GC-resistance
surveillance study in Wales, UK. These nosocomial specimens
originated from either community-acquired (C) or hospital-
acquired (H) infections and were classiﬁed as such (Table 1). All
ESBL-producers were conﬁrmed phenotypically via susceptibility
testing (CLSI) and cephalosporin-clavulanate synergy testing.
Screening for blaCTX-Mwas carried out by multiplex PCR (Woodford
et al., 2006) and subsequent sequence analysis.
blaCTX-M-14 E. coli collected during the work by Liebana et al.
(2006) were included (isolates #6477, #6478, #6479, #6480) as
comparators to the human isolates collected in all further
investigation. In short, samples were collected from rectal swabs
of scour-suffering calves in a North-Wales farm (location
withheld). A history of treatment with amoxicillin-clavulanate,
marboﬂoxacin and cefquinome was noted.
Unless otherwise stated, all bacterial isolates were cultured
overnight at 37 C on CBA plates (Oxoid Ltd., Hampshire, UK) and
stored at 80 C in Microbank Beads (Pro-Lab Diagnostics,
Merseyside, UK).
2.2. Identiﬁcation of blaCTX-M-14
CTX-M Group 9-producing E. coli isolates identiﬁed were
screened for the presence of blaCTX-M-14 using the primers CTX-
M-14-F (50-ggt gac aaa gag agt gca acg-30) and CTX-M-14-R (50-ccg14-positive E. coli.
Plasmid Inc
Type
Conjugative? ISEcp1c MIC (mg/ml)
CTX/Clav CAZ/Clav CIPRO
F/FIB/I1 + U2 32/0.125 2/0.5 0.023
F/FIB/I1 + U2 32/0.25 8/4 0.32
K/F + U2 >128/0.5 2/2 32
K/F + U1 64/0.125 4/0.5 32
F + U1 64/0.5 4/0.5 >128
F + U2 32/0.25 2/0.25 0.5
F + U2 128/0.062 128/
0.062
16
K & F + U2 32/0.062 64/0.062 8
– U2 >128/
0.125
16/1 128
– U2 128/0.25 4/0.5 0.5
F + U2 >128/0.25 >128/
0.25
0.023
F + U2 64/0.5 2/0.5 0.5
F/FIB/I1 + U2 32/0.125 4/1 0.16
I1 + U2 128/0.125 32/4 32
K + U2 >128/0.25 16/1 0.032
K/F + U2 32/0.5 4/4 128
K + U1 64/0.125 8/0.5 128
K + U2 32/1 2/0.25 32
K + U2 128/2 >128/2 32
F/FIA/FIB + U2 4/0.008 0.25/0.5 0.008
– U2 >128/0.5 8/1 0.015
– + U2 32/0.062 4/0.125 0.12
vulanate (Clav).
ry).
 of blaCTX-M-14.
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Amplicons were visualised by gel electrophoresis. CTX-M-14 DNA
was puriﬁed and sequenced using suitable reference sequences
(Accession numbers- blaCTX-M-14a: DQ304479, blaCTX-M-14b:
FJ668792). Bionumerics (Applied Maths, USA) and NCBI applica-
tions were used for sequence annotation.
2.3. Molecular typing of CTX-M-14-producing isolates
blaCTX-M-14-positive E. coli were classiﬁed as one of four
phylogenetic groups by the triplex PCR described by Clermont
et al. (2000) targeting the chuA, yjaA and tspE4C2 sequences.
Clonal relationships were evaluated by preparation of whole
genomic DNA in agarose plugs (Bannerman et al., 1995) and
overnight digestion with XbaI restriction enzyme. Digested frag-
ments were separated by PFGE (9 C, 6 V, 5 to 45s, for 22 h) and
digest patterns visualised under UV. blaCTX-M-14 copy number was
assessed by hybridisation of the PFGE gel with a 32P radio-labelled
blaCTX-M-14 DNA using a random priming kit (Stratagene). Gene
locations were highlighted by incubation with chemi-luminescent
autoradiograph ﬁlms at 80 C.
All E. coli were sequence typed (ST) using a combination of a
two–locus based typing scheme (Weissman et al., 2012) and full
MLST (Wirth et al., 2006).
2.4. Genetic context of blaCTX-M-14
Presence of ISEcp1 upstream of blaCTX-M-14 was conﬁrmed using
primers ISEcp1-U1 (50-aaa aat gat tga aag gtg gt-30) (Leﬂon-Guibout
et al., 2004) and ISEcp1-U2 (50-gca ata ct acct tga ttt ct-30) (Ho et al.,
2005) coupled with the CTX-M-14 R primer. This PCR assay used an
annealing temperature of 58 C for 1.5 min. Positive amplicons
were sequenced and annotated as previously described.Table 2
Characteristics relating to virulence & pathogenic potential of blaCTX-M-14-positive E. co
XbaI Typed Isolate # Sourcea ST Type Phylo Groupb Larvae Surv
105cfu/larva
I #5714 Bangor (C) 538 B2 10% 
#5722 Bangor (C) 538 D 0% 
II #5715 Bangor (C) 718 D 100% 
#5740 Bangor (C) 718 A 90% 
III #3336 Wrexham (C) 405 D 100% 
#3021 Newport (H) 405 D 90% 
#6478 (V) 10 A 0% 
#6479 (V) 10 A 0% 
IV #3081 Newport (C) 38 D 20% 
#3202 Cardiff (C) 38 D 70% 
– #6480 (V) 10 B2 0% 
– #3018 Newport (H) 38 D 100% 
– #5729 Bangor (C) 410 A 30% 
– #2813 Aberystwyth (C) 1193 D 20% 
– #2864 Carmarthen (C) 73 D 100% 
– #3221 Cardiff (C) 641 D 100% 
– #3253 Cardiff (C) 648 D 20% 
– #5682 Bangor (H) 131 D 20% 
– #6477 (V) 226 A 20% 
– #5737 Bangor (C) 131 D 0% 
– #3341 Wrexham (C) 38 D 0% 
– #5720 Bangor (C) 38 D 100% 
a Indicates collection site and origin of specimen (C-community, H-hospital, V-veter
b Phylogenetic grouping of E. coli.
c Virulence factors present.
d XbaI/PFGE types. E. coli shown to be clonal were grouped I, II, III and IV.Genomic DNA prepared in agarose plugs was digested with
S1-nuclease, separated by PFGE, and again hybridised with 32P
radio-labelled blaCTX-M-14 DNA. Subsequent analysis allowed
identiﬁcation of chromosomal and/or plasmidic locations of the
blaCTX-M-14 genes. Replicon types of plasmids carrying blaCTX-M-14
were deduced by multiplex PCR assay (Carattoli et al., 2005).
2.5. Transmissibility of resistance
Conjugative matings was carried out in LB broth (Fisher
Scientiﬁc Ltd.) between blaCTX-M-14-positive E. coli and the recipient
strain GFP-E. coli HB101 (UA6190) (resistant to gentamicin,
kanamycin and rifampicin) (Mata et al., 2010) in a 1:1 ratio.
Transconjugants were positively selected for blaCTX-M-14 gene and
associated phenotype upon LB agar (Fisher Scientiﬁc Ltd., Lough-
borough, UK) containing 50 mg/ml rifampicin and 2 mg/ml
cefotaxime. Gene transfer was further conﬁrmed by PCR.
S1-nuclease digestion was used for plasmid characterisation in
positive transconjugants, as described.
2.6. Evaluation of pathogenic potential
E. coli isolates were screened for a selection of virulence factors,
as described previously by Johnson and Stell (2000); Multiplex
1- sfaS, focG, ﬁmH, papA, papGI. Multiplex 2- papC, papEF, bmaE,
fyuA, papGII & III. Multiplex 3- kpsMT K1, iutA, nfaE, hlyA. Multiplex
4- kpsMT K5, kpsMT II, cnf1, cvaC, PAI. Multiplex 5- traT, kpsMT III,
afa/draBC, gafD.
In vivo infection models used larvae of the wax moth Galleria
mellonella and were infected with bacterial loads of approximately
1.2 107, 106, 105 and 104 cfu/larva. 10 ml of bacterial suspension
was injected into the larval haemocoel through the rear-left pro-
leg. Larvae were incubated in sterile petri plates at 37 C for 72 h.
Death was accepted when the larvae no longer responded to touch,li.
ival vs Infection Challenge VFsc
 106cfu/larva 107cfu/larva
0% 0% ﬁmH, fyuA, PAI, cvaC, traT, kpsMT II, kpsMT K1
0% 0% ﬁmH, fyuA, PAI, cvaC, traT, kpsMT II, kpsMT K1
80% 20% ﬁmH, iutA, cvaC, traT
60% 10% ﬁmH, iutA, cvaC, traT
70% 30% ﬁmH, fyuA, traT
70% 30% ﬁmH, fyuA, PAI, traT
0% 0% ﬁmH, fyuA, iutA, traT, papA, papC
0% 0% ﬁmH, fyuA, iutA, traT, papA, papC
20% 0% ﬁmH, fyuA, iutA, PAI, traT, kpsMT II
20% 0% ﬁmH, fyuA
0% 0% ﬁmH, bmaE, iutA, cvaC, traT, papA, papC
90% 90% ﬁmH, fyuA, traT
0% 0% ﬁmH, fyuA, iutA, cvaC, traT
0% 0% ﬁmH, fyuA, iutA, PAI, kpsMT II
100% 20% ﬁmH, fyuA, hlyA, PAI, cnf1, traT, kpsMT II
30% 10% ﬁmH, fyuA, traT, papC
20% 0% ﬁmH, fyuA, PAI, traT
0% 0% ﬁmH, fyuA, iutA, PAI, afa/draBC, traT
0% 0% ﬁmH, bmaE, iutA, traT
0% 0% ﬁmH, fyuA, iutA, PAI, traT
0% 10% ﬁmH, fyuA, papC
100% 20% ﬁmH, traT
inary).
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endpoint.
3. Results
3.1. Summary of targeted surveillance of 3GC-resistance
Of 580 cefpodoxime-resistant Enterobacteriaceae received from
participating hospitals across Wales as part of the targeted
surveillance of 3GC-resistance 26 were found to harbour CTX-M
Group 9 enzymes and 19 of these were conﬁrmed for the presence
of blaCTX-M-14 by PCR (18 E. coli, see Table 1, and one Klebsiella
pneumoniae, isolate #2867, absent from Table 1). Remaining CTX-
M group 9 members were found to carry blaCTX-M-27 (n = 1) and
blaCTX-M-9 (n = 6; all collected from the same hospital).
3.2. Description of CTX-M-14-producers
Subsequent analysis was performed on CTX-M-14-producing E.
coli from both nosocomial and veterinary sources (Tables 1 and 2).
All CTX-M-14-producers were resistant to both cefotaxime and
ceftazidime. All expressed conﬁrmed ESBL-phenotypes by synergy
testing against potassium clavulanate (CLAV). Co-resistance to
ciproﬂoxacin, and gentamicin was common in CTX-M-14-pro-
ducers with rates of 52.2% and 43.5%, respectively. No resistance to
nitrofurantoin or mecillinam was found (data not shown).
Sources of nosocomial E. coli were geographically diverse across
6 different hospital sites (Table 1), and carriage rates of blaCTX-M-14
in cephalosporin-resistant populations increasing in correlation
with the proximity to the Liebana et al. (2006) index study farm.
84% of human E. coli were isolated from community-sourced
patients. Only three were classiﬁed as hospital-acquired infections.
blaCTX-M-14-positive E. coli were variably assigned to phyloge-
netic groups A, D and B2 (Tables 1 and 2). Sixteen different XbaI
clonal types of E. coli were identiﬁed, amongst 12 different STs
(Table 2, Supplementary Fig. 1). Here, blaCTX-M-14 was most
commonly carried by E. coli of ST38. Clone I E. coli, (ST538, isolates
#5714 and #5722), were both collected at Bangor hospital, as were
Clone II E. coli (ST718, isolates #5715 & #5740) (Tables 1 and 2).
Clone III E. coli (ST10, isolates #3336, #3021, #6478 & #6479) were
found across various collection sites; the index North Wales dairy
farm (Liebana et al., 2006; location withheld) Wrexham, Newport
(separated by a distance of approximately 126 miles), respectively.
Clone IV, E. coli (ST38, isolates #3081 and #3202), also originateFig. 1. A) PFGE of S1-nuclease Digestion of CTX-M-14-producing Enterobacteriaceae and
with 32P- radiolabelled blaCTX-M-14 DNA.
X: Molecular Weight Lambda Marker. L1: #5682-Wild Type. L2: #5682-Transconjugant. L
#5740-WT. L10: #5740-T. L11: #3021-WT. L12: #3021-T. L13: #2867-WT. L14: #2867-Tfrom two locations, Newport and Cardiff (separated by a distance
of 15 miles), respectively.
3.3. Genetic context of blaCTX-M-14
75 kb IncK and 100 kb IncF plasmids were the most common
host constructs of blaCTX-M-14 (Fig. 1, Table 1), both found in 36.4%
(n = 8) of isolates. In addition, a 150 kb blaCTX-M-14-positive plasmid
was found in isolates #5737 and #3336, and a 25 kb blaCTX-M-14-
positive plasmid in isolate #6479. S1-digests identiﬁed the
location of blaCTX-M-14 upon the chromosome of many E. coli,
either in isolation (isolates #3341, #5720, #3081, #3202) or in
addition to a plasmidic copy of the gene (isolates #5714, #5715,
#6477, #6478) (Fig. 1).
All blaCTX-M-14-positive plasmids were conjugative in nature and
transferred blaCTX-M-14 successfully to the GFP-E. coli HB101
recipient. In three transconjugants, blaCTX-M-14 was located on a
plasmid construct different in size to that of its parent. E. coli
#3021 carries blaCTX-M-14 upon a 75 kb plasmid, and on an
additional 25 kb plasmid in its corresponding transconjugant
(Fig. 1). Similar phenomenon were seen for isolates #2813 and
#3336, suggesting recombination events resulting in relocation of
the blaCTX-M-14 gene or re-structuring of plasmids. blaCTX-M-14 was
conjugatively transferred to the GFP-recipient from #5720, despite
only identiﬁcation of a chromosomal copy of the gene within the
donor strain. blaCTX-M-14 was found ubiquitously downstream of
ISEcp1 upon all constructs in our test sample, both in complete
(n = 20) and truncated forms, as with E. coli #5740, #3336 and
#3253.
3.4. Pathogenicity of CTX-M-14-producing E. coli
Distribution of virulence factors in our test sample can be seen
in Table 2. The type 1 ﬁmbriae gene ﬁmH was the most commonly
found virulence marker, present in all E. coli. The traT gene,
involved in both serum resistance and plasmid mobilisation, was
found in all but three E. coli (isolates #3202, #3341 and #2813). The
genes focG, sfaS, rfc, nfaE, gafD, papEF, papG I, II & III, kpsMT III &
K5 were not found in any isolates. All other virulence markers were
found at varying rates throughout the sample, as outlined (see
Table 2). The average virulence score of veterinary E. coli was 5.8,
compared to 4.4 for E. coli originating from hospitalised patients.
No signiﬁcant correlation between virulence score and phyloge-
netic group was seen. corresponding transconjugants B) Autoradiograph of PFGE Gel after hybridisation
3: #5714-WT. L4: #5714-T. L5:#5722-WT. L6:5722-T. L7: #5729-WT. L8: #5729-L. L9:
.
Fig. 2. A) Kaplan-Meier Survival Analysis of blaCTX-M-14–carrying Human & Cattle E. coli at 106cfu/larva. B) Percent of blaCTX-M-14-carrying Human & Cattle E. coli Reaching
LD90 at 106cfu/larva. A) blaCTX-M-14 Human Specimens: n = 18. blaCTX-M-14 Cattle Specimens: n = 4. Log-rank (Mantel-Cox) test P value- 0.0001. Signiﬁcant Difference?- Yes. B)
blaCTX-M-14 Human Specimens: n = 18. blaCTX-M-14 Cattle Specimens: n = 4. For 24, 48 & 72Hrs respectively: blaCTX-M-14 Human- 27.8%, 38.9% 38.9%. blaCTX-M-14 Cattle- 100%,
100%, 100%.
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19 of cases, transconjugants #5740-T, #3081-T, #2864-T, #3221-T
and #3253-T the exceptions. Other genes conjugatively transferred
included fyuA (yersiniabactin) from isolates #6479 and #5720, the
P ﬁmbriae genes papA and papC (#6479), iutA (aerobactin) and cvaC
(colicin V) from #5715, and ﬁnally PAI (undeﬁned pathogenicity
island marker) and kpsMT II (group II LPS capsule marker) from
isolate #5722.
Kaplan-Meier survival analysis showed veterinary E. coli to be
signiﬁcantly more virulent than nosocomial E. coli isolates when
used as an infective challenge in the G. mellonella infection model
(p  0.05) (Fig. 2). 100% of veterinary E. coli reached LD90 rates at
105, 106 and 107 cfu/larva. Corresponding rates of nosocomial E.
coli achieving LD90 were 22.2%, (4/22), 38.9% (7/18) and 66.7% (12/
18), respectively. No correlation between virulence potential of the
E. coli, and their relative phylogenetic group classiﬁcation, was
seen (p > 0.1). Additionally, E. coli of the highest pathogenic
potential included ST538, ST10 and ST131. Interestingly, E. coli
ST131 did not carry signiﬁcantly higher pathogenic potential, or
record higher VF scores, than many of our STs described.
4. Discussion
We aimed to characterise carriage of blaCTX-M-14 within
cephalosporin resistant Enterobacteriaceae infections in Wales,
in context to strains and ﬁndings of Teale et al. (2005) and Liebanaet al. (2006). We describe transmissible blaCTX-M-14 genes within
the microbial populations of both human and cattle specimens,
seemingly via a combination of horizontal gene transfer and clonal
dissemination.
Table 1 shows 16 varying XbaI types across 12 E. coli STs with
4 multi-isolate clones identiﬁed, as highlighted. This clonal
diversity highlights the importance of sampling multiple and
varied geographical locations in such work. Such clonal variation
also reﬂects previous ﬁndings (Valverde et al., 2009; Pitout et al.,
2005a). Our ﬁndings highlight the possible role of clonal
propagation in disseminating resistance among patients of a
single nosocomial environment (as is the case with Clones I & II),
and within community/environmental settings as with isolates
#3081 and #3021 (Clone IV, ST38) found at Newport and Cardiff,
respectively. 84% of the blaCTX-M-14-positive E. coli were isolated
from community-acquired infections, further alluding to this route
of spread, reﬂecting global epidemiology of CTX-M-positive
infections (Pitout et al., 2005a,b). It should be noted, however,
that patients with community-acquired infections may have had
signiﬁcant contact with healthcare establishments. E. coli Clone III
(ST10) was found in patients across two hospitals and also of
veterinary origin. Evidence of zoonotic transfer of CTX-M-positive
clones is notable but limited (Liebana et al., 2012), and in this case
the nature and direction of these possible disseminations is
unknown. To our knowledge this is the ﬁrst report of bla CTX-M-
14 with the strain backgrounds of E. coli ST538, ST718 and ST73.
42 J.M. Tyrrell et al. / Veterinary Microbiology 186 (2016) 37–43blaCTX-M-14 was ubiquitously downstream of an ISEcp1 element.
In 3 E. coli, blaCTX-M-14 was found downstream of a truncated copy
of the element ISEcp1, in accordance with previous ﬁndings by
Eckert et al. (2005). blaCTX-M-14 was primarily located upon 100 kb
IncK plasmids, reﬂecting the plasmid characteristics of the index
isolate (Liebana et al., 2006; Cottell et al., 2011). 75 kb IncF
plasmids were also described in both clinical and veterinary
isolates. Of note is the discovery of these blaCTX-M-14 genes upon the
chromosome, either in isolation or in addition to a plasmidic copy.
Such ﬁndings are sparsely reported (Kim et al., 2011) with CTX-M
genes rarely chromosomal outside of Proteus spp. (Song et al.,
2011). Given rates of recombination and transposition associated
with resistance elements and the bacterial genome as a whole, it
should be of no surprise that such events may occur. Hybridisation
of XbaI digests with radio-labelled blaCTX-M-14 DNA conﬁrmed
multiple gene copies within the E. coli genome (Data not shown).
This highlights the horizontal gene transfer of blaCTX-M-14 between
multiple genetic constructs and locations in the dissemination of
the gene.
Veterinary E. coli carry a more signiﬁcant pathogenic potential
than their clinical counterparts in a G. mellonella infection model
(see Fig. 1 and Table 2). Veterinary E. coli also carry a higher mean
VF score than that of clinical E. coli. Does this represent an
evolutionary trade-off between virulent and resistant phenotypes
to successfully navigate their diverse niches? In nosocomial
settings, where antibiotic selective pressure would be much
greater, multi-resistance as opposed to a wholly pathogenic
approach is of a greater survival advantage. The transfer of
virulence markers in addition to the blaCTX-M-14 gene adds further
signiﬁcance to the study of genetic dissemination of such
resistance determinants. The convergence of both pathogenic
and resistance evolutionary strategies in this way may act to
further promote the persistence and dissemination of multi-
resistant organisms in hospitals and the community.
4.1. Concluding remarks
This study describes a blaCTX-M-14-positive E. coli population
across microbial populations of both humans and livestock.
Evidence has been presented for roles of horizontal gene transfer,
via conjugative plasmids, and clonal expansion, in this dissemina-
tion. Growing evidence suggests the potential of livestock to act as
both reservoirs and endpoints of antibiotic-resistant organisms,
acting as vectors to facilitate this spread. However, conclusions
regarding reservoirs of community-acquired and zoonotic infec-
tions are still contentious, and cannot be deﬁned here. Use of
antibiotics in livestock may be an important factor promoting
emergence and spread of multidrug resistant infections, the risk
factors evaluated extensively (Snow et al., 2012). Given our
relatively intimate relationship with livestock and our environ-
ment, exchange between microbial populations and route to
human infection cannot and should not be dismissed. Moreover,
given the higher pathogenicity potential with veterinary E. coli
isolates alongside a multidrug resistant phenotype, surveillance is
pertinent to understand and prevent further dissemination of
multi-drug resistant organisms through livestock and human
populations.
Funding
This study was jointly funded by the Public Health Wales and
AHVLA (Animal Health & Veterinary Laboratory Agency). There is
no conﬂict of interest within this work.Transparency agreement
None to declare.
Acknowledgements
Thanks go to the staff of SACU (Specialist Antimicrobial
Chemotherapy Unit) and the Department of Medical Microbiology
& Infectious Diseases, Institute of Infection & Immunity, Cardiff
University. Thanks also go to Dr Nick Coldham of the AHVLA for
supplying us with the cattle isolates used in this study.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.vetmic.
2016.02.007.
References
Bae, I.K., Lee, Y.N., Lee, W.G., Lee, S.H., Jeong, S.H., 2007. Novel complex class
1 integron bearing an ISCR1 element in an Escherichia coli carrying the blaCTX-M-
14 gene. Antimicrob. Agents Chemother. 51, 3017–3019.
Bannerman, T.L., Hancock, G.A., Tenover, F.C., Miller, J.M., 1995. Pulsed-ﬁeld gel
electrophoresis as a replacement for bacteriophage typing of Staphylococcus
aureus. J. Clin. Microbiol. 33, 551–555.
Blanc, V., Mesa, R., Saco, M., Lavilla, S., Prats, G., Miro, E., Navarro, F., Cortes, P.,
Llagostera, M., 2006. ESBL- and plasmidic class C b-lactamase-producing E. coli
strains isolated from poultry: pig and rabbit farms. Vet. Microbiol.118, 299–304.
Bonnet, R., 2004. Growing group of extended-spectrum beta-lactamases: the CTX-
M enzymes. Antimicrob. Agents Chemother. 48, 1–14.
Brinas, L., Moreno, M.A., Zarazaga, M., Porrero, C., Saenz, Y., Garcia, M., Dominguez,
L., Torres, C., 2003. Detection of CMY-2CTX-M-14, and SHV-12 b-lactamases in
Escherichia coli fecal-Sample isolates from healthy chickens. Antimicrob. Agents
Chemother. 47, 2056–2058.
Canton, R., Coque, T.M., 2006. The CTX-M b-lactamase pandemic. Curr. Opin.
Microbiol. 9, 466–475.
Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K.L., Threlfall, E.J., 2005.
Identiﬁcation of plasmids by PCR-based replicon typing. J. Microbiol. Methods
63, 219–228.
Clermont, O., Bonacorsi, S., Bingen, E., 2000. Rapid and simple determination of
Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66,
4555–4558.
Costa, D., Poeta, P., Saenz, Y., Vinue, L., Coelho, A.C., Matos, M., Rojo-Bezares, B.,
Rodrigues, J., Torres, C., 2008. Mechanisms of antibiotic resistance in Escherichia
coli isolates recovered from Wild Animals. Microb. Drug Resist. 14,
71–77.
Cottell, J.L., Webber, M.A., Coldham, N.G., Taylor, D.L., Cerdeno-Tarrage, A.M., Hauser,
H., Thomson, N.R., Woodward, M.J., Piddock, L.J., 2011. Complete sequence and
molecular epidemiology of IncK epidemic plasmid encoding blaCTX-M-14. Emerg.
Infect. Dis. 17, 645–652.
Eckert, C., Gautier, V., Arlet, G., 2005. DNA Sequence analysis of the genetic
environment of various blaCTX-M genes. J. Antimicrob. Chemother. 57, 14–23.
Goncalves, A., Igrejas, G., Radhouani, Estepa V, Pacheco, R., Monteiro, R., Brito, F.,
Guerra, A., Petrucci-Fonseca, F., Torres, C., Poeta, P., 2011. Iberian Wolf as a
reservoir of extended- spectrum b-lactamase-producing Escherichia coli of the
TEM, SHV and CTX-M Groups. Microb. Drug Resist. 18, 215–219.
Hawkey, P.M., 2008. Prevalence and clonality of extended-spectrum b-lactamases
in Asia. Clin. Microbiol. Infect. 14, 159–165.
Hawkey, P.M., Jones, A.M., 2009. The changing epidemiology of resistance. J.
Antimicrob. Chemother. 64, i3–i10.
Hernandez, J., Bonnedahl, J., Eliasson, I., Wallensten, A., Comstedt, P., Johansson, A.,
Granholm, S., Melhus, A., Olsen, B., Drobni, M., 2010. Globally disseminated
human pathogenic Escherichia coli of O25b-ST131 clone harbouring blaCTX-M-15,
found in Glaucous-winged gull at remote Commander Islands, Russia. Environ.
Microbiol. Rep. 2, 329–332.
Ho, P.L., Shek, R.H., Chow, K.W., Duan, R.S., Mak, G.C., Lai, E.L., Yam, W.C., Tsang, K.W.,
Lai, W.M., 2005. Detection and characterisation of extended-spectrum beta-
lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong,
2000–2002. J. Antimicrob. Chemother. 55, 326–332.
Ho, P.L., Yeung, M.K., Lo, W.U., Tse, H., Li, Z., Lai, E.L., Chow, K.H., To, K.K., Yam, W.C.,
2012. Predominance of pHKO1-like incompatibility group IncFII plasmids
encoding CTX-M-14 among extended-spectrum beta-lactamase-producing
Escherichia coli in Hong Kong, 1996–2008. Diagn. Microbiol. Infect. Dis. 73, 182–
186.
Jiang, H.X., Tang, D., Liu, Y.H., Zhang, X.H., Zeng, Z.L., Xu, L., Hawky, P.M., 2012.
Prevalence and characteristics of b-lactamase and plasmid-mediated
quinolone resistance genes in Escherichia coli isolated from farmed ﬁsh in China.
J. Antimicrob. Chemother. 67, 2350–2353.
J.M. Tyrrell et al. / Veterinary Microbiology 186 (2016) 37–43 43Johnson, J.R., Stell, A.L., 2000. Escherichia coli strains from patients with urosepsis in
relation to phylogeny and host compromise. J. Infect. Dis. 181, 261–272.
Kim, J., Bae, I.K., Jeong, S.H., Chang, C.L., Lee, C.H., Lee, K., 2011. Characterization of
IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli
from Korea. J. Antimicrob. Chemother. 66, 1263–1268.
Leﬂon-Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelﬁ, M.C., Duportail, F.,
Heym, B., Bingen, E., Nicolas-Chanoine, M.H., 2004. Emergence and spread of
three clonally. related virulent isolates of CTX-M-15-producing escherichia coli
with variable resistance to aminoglycosides and tetracycline in a french
geriatric hospital. Antimicrob. Agents Chemother. 48, 3736–3742.
Liebana, E., Batcherlor, M., Hopkins, K.L., Clifton-Hadley, F.A., Teale, C.J., Foster, A.,
Barker, L., Threlfall, E.J., Davies, R.H., 2006. Longitudinal farm study of extended-
spectrum beta- lactamase-mediated resistance. J. Clin. Microbiol. 44, 1630–
1634.
Liebana, E., Carattoli, A., Cogue, T.M., Hasman, H., Magiorakos, A.P., Mevius, D., Peixe,
L., Poirel, L., Schuepbach-Regula, G., Torneke, K., Torren-Edo, J., Torres, C.,
Threlfall, J., 2012. Public health risks of enterobacterial isolates producing
extended-Spectrum b-lactamases in food and food-producing animals an EU
persepctive of epidemiology, analytical methods, risk factors and control
options. Clin. Infect. Dis. 56, 1030–1037.
Mata, C., Miro, E., Mirelis, B., Garcillan-Barcia, M.P., de la Cruz, F., Coll, P., Navarro, F.,
2010. In vivo transmission of a plasmid coharbouring bla and qnrB genes between
Escherichia coli and Serratia marcescens. FEMS Microbiol. Lett. 308, 24–28.
Matsumoto, Y., Ikeda, F., Kamimura, T., Yokota, Y., Mine, Y., 1988. Novel plasmid-
mediated beta-lactamase from Escherichia coli that inactivated oxyimino-
cephalosporins. Antimicrob. Agents Chemother. 32, 1243–1246.
Navarro, F., Mesa, R.J., Miro, E., Gomez, L., Mirelis, B., Coll, P., 2007. Evidence for
convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalence.
FEMS Microbiol. Lett. 2713, 120–123.
Olson, A.B., Silverman, M., Boyd, D.A., McGeer, A., Willey, B.M., Pong-Porter, V.,
Daneman, N., Mulvey, M.R., 2005. Identiﬁcation of a progenitor of the CTX-M-
9 group of extended—spectrum beta-lactamases from Kluyvera georgina
isolated in Guyana. Antimicrob. Agents Chemother. 49, 2112–2115.
Pitout, J.D.D., Gregson, D.B., Church, D.L., Elsayed, S., Laupland, K.B., 2005a.
Community-wide outbreaks of clonally related CTX-M-14 b-Lacatamse-
Producing Escherichia coli strains in the calgary health region. J. Clin. Microbiol.
43, 2844–2849.
Pitout, J.D.D., Nordmann, P., Laupland, K.B., Poirel, L., 2005b. Emergence of
Enterobacteriaceae producing extended-spectrum b-lactamases (ESBLs) in the
community. J. Antimicrob. Chemother. 56, 52–59.Smet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Catry, B., Herman, L.,
Haesebrouck Butaye, P., 2008. Diversity of extended-spectrum beta-lactamases
and class C beta-lactamases among cloacal Escherichia coli Isolates in Belgian
broiler farms. Antimicrob. Agents Chemother. 52, 1238–1243.
Snow, L.C., Wearing, H., Stephenson, B., Teale, C.J., Coldham, N.G., 2011. Investigation
of the presence of ESBL-producing Escherichia coli in the North Wales and West
Midlands areas of the UK in 2007–2008 using scanning surveillance. Vet. Rec.
169, 656.
Snow, L.C., Warner, R.G., Cheney, T., Wearing, H., Stokes, M., Harris, K., Teale, C.J.,
Coldham, N.G., 2012. Risk factors associated with extended-spectrum beta-
lactamase Escherichia coli (CTX-M) on dairy farms in North West England and
North Wales. Prev. Vet. Med. 106, 225–234.
Song, W., Kim, J., Bae, I.K., Jeong, S.H., Seo, Y.H., Shin, J.H., Jang, S.J., Uh, Y., Shin, J.H.,
Lee, M.K., Lee, K., 2011. Chromosome-encoded AmpC and CTX-M extended-
spectrum b-lactamases in clinical isolates of Proteus mirabilis from Korea.
Antimicrob. Agents Chemother. 55, 1414–1419.
Teale, C.J., Barker, L., Foster, A.P., Liebana, E., Batchelor, M., Livermore, D.M., Threlfall,
E.J., 2005. Extended-spectrum beta-lactamase detected in E. coli recovered from
calves in Wales. Vet. Rec. 156, 186–187.
Valverde, A., Canton, R., Pilar Garcillan-Barcia, M., Novais, A., Galan, J.C., Alvarado, A.,
de la Cruz, F., Baquero, F., Coque, T.M., 2009. Spread of blaCTX-M-14 is driven
mainly by IncK plasmids disseminated among escherichia coli phylogroups A,
B1 and d in Spain’. Antimicrob. Agents Chemother. 53, 5204–5212.
Wang, X., Chen, J., Kang, Y., Jiang, N., An, S., Gao, Z., 2012. Prevalence and
characterisation of plasmid-mediated blaESBL with their genetic environment in
Escherichia coli and Klebsiella pneumoniae in patients with pneumonia. Chin.
Med. J. (Engl.) 125, 894–900.
Weissman, S.J., Johnson, J.R., Tchesnokova, V., Billig, M., Dykhuizen, D., Riddell, K.,
Rogers, P., Qin, X., Butler-Wu, S., Cookson, B.T., Fang, F.C., Scholes, D.,
Chattopadhyay, S., Sokurenko, E., 2012. High-resolution two-locus clonal typing
of extraintestinal pathogenic E. coli. Appl. Environ. Microbiol. 78, 1353–1360.
Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L.H., Karch, H., Reeves, P.R.,
Maiden, M.C.J., Ochman, H., Achtman, M., 2006. Sex and virulence in Escherichia
coli: an evolutionary perspective. Mol. Microbiol. 60, 1136–1151.
Woodford, N., Fagan, E.J., Ellington, M.J., 2006. Multiplex PCR for rapid detection of
genes encoding CTX-M extended-spectrum b-lactamases. J. Antimicrob.
Chemother. 57, 154–155.
